Clinical Trials Logo

Clinical Trial Summary

The "Extended VALHUDES" study is a Clinical Performance / Diagnostic Test Accuracy Study that aims to extend validation, achieved as part of the "Belgian VALHUDES", of HPV testing using BD Onclarity on samples collected using Copan's devices for dry self-sampling of vaginal material and for first-void urine: FLOQSwab® 5E089N and UriSponge™.


Clinical Trial Description

Women accessing the Colposcopy Centres for a colposcopy examination and fulfilling the selection criteria will be asked, after written informed consent, to self-collect a first-void urine (with UriSponge™ 8E031S100 device) and a vaginal sample (with FLOQSwab® 5E089N device), prior to undergoing colposcopy. Just before colposcopic examination, a clinician will also collect a cervical sample using a Cervex-Brush. A colposcopy-targeted biopsy or histology following excisional treatment of a cervical precancer lesion will be undertaken if appropriate. The colposcopy and/or histological findings will be used as the gold standard. In case of normal satisfactory colposcopic findings without biopsy taking, colposcopy will provide the study outcome. Virological accuracy of HPV testing using: [a] BD Onclarity on FLOQSwab® 5E089N vaginal self-samples, [b] BD Onclarity on UriSponge™ 8E031S100 urine specimens, will be compared to BD Onclarity testing on a cervical samples collected by a clinician. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04788849
Study type Observational
Source University of Milano Bicocca
Contact Marc Arbyn, MD
Phone +3226425021
Email marc.arbyn@sciensano.be
Status Recruiting
Phase
Start date March 8, 2021
Completion date February 28, 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03196180 - Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia Early Phase 1
Active, not recruiting NCT04484415 - Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL) Phase 3
Not yet recruiting NCT06258564 - The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization
Not yet recruiting NCT06273553 - A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3 Phase 1/Phase 2
Active, not recruiting NCT02149030 - Effectiveness of Cervical Screening in HPV Vaccinated Women Phase 4
Completed NCT01550783 - Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening N/A
Enrolling by invitation NCT04755517 - Effectiveness of Cervical Screening in Unvaccinated, Herd Effect Protected Women (HPV400) N/A
Completed NCT02811367 - The HPV Self-test as a Test of Cure in Madagascar N/A
Completed NCT00081263 - Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia Phase 2
Recruiting NCT05405270 - Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Completed NCT04312737 - Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma Virus
Completed NCT02067468 - Optimal Strategy for the Management of ASCUS Cytology in Health Care Services of Medellin, Colombia N/A
Completed NCT02354534 - Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3) Phase 1
Recruiting NCT03366493 - The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection Phase 3
Active, not recruiting NCT03064087 - Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples
Recruiting NCT05851079 - Accurate Screening and Prevention of Cervical Lesions-- Development of Accurate Screening Methods for Cervical Lesions
Recruiting NCT03274206 - A Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3) Phase 2